How to buy NanoVibronix stock | $0.8179

NanoVibronix, Inc is a medical devices business based in the US. NanoVibronix shares (NAOV) are listed on the NASDAQ and all prices are listed in US Dollars. NanoVibronix employs 10 staff and has a trailing 12-month revenue of around USD$620,000.

How to buy shares in NanoVibronix

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for NanoVibronix. Find the stock by name or ticker symbol: NAOV. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until NanoVibronix reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$0.8179, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of NanoVibronix, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of NanoVibronix. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

NanoVibronix share price

Use our graph to track the performance of NAOV stocks over time.

NanoVibronix shares at a glance

• Key figures

Information last updated 2020-12-25.

Latest market close	USD$0.8179
52-week range	USD$0.535 - USD$3.015
50-day moving average	USD$0.7857
200-day moving average	USD$1.1376
Wall St. target price	USD$10.5
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.921

Buy NanoVibronix shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy NanoVibronix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of NanoVibronix, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NanoVibronix price performance over time

Historical closes compared with the close of $0.8179 from 2020-12-18

1 week (2021-01-07)	-8.10%
1 month (2020-12-17)	-5.34%
3 months (2020-10-16)	22.62%
6 months (2020-07-17)	-54.56%

1 year (2020-01-17)	-70.44%
2 years (2019-01-17)	-75.94%
3 years (2018-01-17)	4.45
5 years (2016-01-13)	4.15

NanoVibronix financials

Revenue TTM	USD$620,000
Gross profit TTM	USD$281,000
Return on assets TTM	-77%
Return on equity TTM	-164.2%
Profit margin	0%
Book value	$0.216
Market capitalisation	USD$14.7 million

TTM: trailing 12 months

Shorting NanoVibronix shares

There are currently 152,395 NanoVibronix shares held short by investors – that's known as NanoVibronix's "short interest". This figure is 74.4% up from 87,371 last month.

There are a few different ways that this level of interest in shorting NanoVibronix shares can be evaluated.

NanoVibronix's "short interest ratio" (SIR)

NanoVibronix's "short interest ratio" (SIR) is the quantity of NanoVibronix shares currently shorted divided by the average quantity of NanoVibronix shares traded daily (recently around 662586.95652174). NanoVibronix's SIR currently stands at 0.23. In other words for every 100,000 NanoVibronix shares traded daily on the market, roughly 230 shares are currently held short.

However NanoVibronix's short interest can also be evaluated against the total number of NanoVibronix shares, or, against the total number of tradable NanoVibronix shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NanoVibronix's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 NanoVibronix shares in existence, roughly 10 shares are currently held short) or 0.0114% of the tradable shares (for every 100,000 tradable NanoVibronix shares, roughly 11 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NanoVibronix.

Find out more about how you can short NanoVibronix stock.

NanoVibronix share dividends

We're not expecting NanoVibronix to pay a dividend over the next 12 months.

NanoVibronix share price volatility

Over the last 12 months, NanoVibronix's shares have ranged in value from as little as $0.535 up to $3.015. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NanoVibronix's is -0.0835. This would suggest that NanoVibronix's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, NanoVibronix has bucked the trend.

NanoVibronix overview

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was founded in 2003 and is based in Elmsford, New York.

Frequently asked questions

• What percentage of NanoVibronix is owned by insiders or institutions?

  Currently 7.645% of NanoVibronix shares are held by insiders and 7.172% by institutions.

• How many people work for NanoVibronix?

  Latest data suggests 10 work at NanoVibronix.

• When does the fiscal year end for NanoVibronix?

  NanoVibronix's fiscal year ends in December.

• Where is NanoVibronix based?

  NanoVibronix's address is: 525 Executive Boulevard, Elmsford, NY, United States, 10523

• What is NanoVibronix's ISIN number?

  NanoVibronix's international securities identification number is: US63008J1088

• What is NanoVibronix's CUSIP number?

  NanoVibronix's Committee on Uniform Securities Identification Procedures number is: 63008J108